Repplinger Sébastien, Jacquier Hervé, Verret Alexandre, Berçot Béatrice, Munier Anne-Lise, Le Dorze Matthieu, Sonneville Romain, Chousterman Benjamin, Mebazaa Alexandre, Deniau Benjamin
Department of Anesthesia, Burn and Critical Care, University Hospitals Saint-Louis - Lariboisière, Assistance Publique-Hôpitaux de Paris (APHP), Paris , France.
UMR-S 942, INSERM, MASCOT, Paris University, Paris , France.
Neurosurgery. 2024 Dec 5;97(1):223-233. doi: 10.1227/neu.0000000000003300.
Diagnosing ventriculostomy-related infection (VRI), a common complication after external ventricular drainage (EVD), is challenging and often associated with delayed initiation of antibiotic therapy. We aimed to develop a stewardship score to help in the decision of antibiotic therapy initiation when VRI is suspected.
This retrospective, single-center cohort study included patients admitted to the intensive care unit after EVD placement who were suspected of having healthcare-associated ventriculitis and/or meningitis between January 1, 2012, and August 31, 2022. A multiple logistic regression model was used to identify factors associated with the development of healthcare-associated meningitis or ventriculitis after EVD placement.
A total of 331 patients were included. Eighty-one (23%) patients developed VRI between January 1, 2012, and August 31, 2022, whereas 250 (77%) did not (from January 1, 2018, to August 31, 2022). VRI-associated factors were EVD count >1 (odds ratio [OR] 3.69, P < .001), EVD duration >8 days (OR 6.71, P < .001), immunosuppression (OR 3.45, P = .028), recent neurosurgery (OR 7.74, P < .001), cerebrospinal fluid leak (OR 6.08, P < .001), and prophylactic antimicrobials (OR 0.26, P < .001). The VEntriculostomy-Related Infection score (VERI) score categorized VRI risk into 4 levels, with an area under the curve of 0.84.
The VERI score is a robust, predictive tool for assessing the risk of VRI in patients with EVD, potentially guiding more judicious use of antibiotic therapy in the intensive care unit setting.
诊断脑室造瘘相关感染(VRI)是体外脑室引流(EVD)术后常见的并发症,具有挑战性,且常与抗生素治疗开始延迟相关。我们旨在制定一个管理评分,以帮助在怀疑发生VRI时决定是否开始抗生素治疗。
这项回顾性单中心队列研究纳入了2012年1月1日至2022年8月31日期间因EVD置入后入住重症监护病房且怀疑发生医疗相关脑室炎和/或脑膜炎的患者。采用多元逻辑回归模型确定EVD置入后发生医疗相关脑膜炎或脑室炎的相关因素。
共纳入331例患者。2012年1月1日至2022年8月31日期间,81例(23%)患者发生VRI,而250例(77%)患者未发生(2018年1月1日至2022年8月31日)。与VRI相关的因素包括EVD次数>1(比值比[OR]3.69,P<.001)、EVD持续时间>8天(OR 6.71,P<.001)、免疫抑制(OR 3.45,P=.028)、近期神经外科手术(OR 7.74,P<.001)、脑脊液漏(OR 6.08,P<.001)和预防性使用抗菌药物(OR 0.26,P<.001)。脑室造瘘相关感染评分(VERI)将VRI风险分为4个等级,曲线下面积为0.84。
VERI评分是评估EVD患者VRI风险的一种可靠的预测工具,可能有助于在重症监护病房环境中更明智地使用抗生素治疗。